Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018

<b>Background:</b> The association of vitamin D with metabolic dysfunction-associated fatty liver disease (MAFLD) remained unclear. This study aimed to examine the relationships of total 25-hydroxyvitamin D [25(OH)D, the sum of 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub>], 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD. <b>Methods:</b> We used the National Health and Nutrition Examination Survey of the 2017-2018 cycle for our present analysis. Binary logistic regression analyses were conducted to explore the associations of total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD after adjusting for confounders. Interaction tests were conducted to compare the association between 25(OH)D and MAFLD in subgroups. <b>Results:</b> The final analysis included 4605 subjects. After adjustment for confounders, the odds of MAFLD decreased with increasing concentrations of total 25(OH)D (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.29-0.68; <i>p</i> for trend < 0.001). Serum 25(OH)D<sub>3</sub> showed a strong inverse association with MAFLD (OR, 0.39; 95% CI, 0.25-0.59; <i>p</i> for trend < 0.001). In addition, participants with lower epi-25(OH)D<sub>3</sub> levels had a higher likelihood of MAFLD, as demonstrated in both quartile and continuous models (OR, 0.77; 95% CI, 0.60-0.99; <i>p</i>=0.041). After stratification by lipid status, inverse associations of total 25(OH)D and 25(OH)D<sub>3</sub> with MAFLD were found only in dyslipidemic participants (<i>p</i> for interaction < 0.001). A sex-specific interaction was also noted for 25(OH)D<sub>3</sub>, showing stronger effects in women than in men (<i>p</i>=0.036). <b>Conclusions:</b> Low serum total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> were significantly associated with a higher prevalence of MAFLD. These associations showed nonlinear patterns and were particularly evident among participants with dyslipidemia, with 25(OH)D<sub>3</sub> demonstrating stronger protective effects in women than in men. Given the cross-sectional design, causality cannot be inferred, and further prospective studies are required to confirm these findings.

Authors

Institutions

Publication Details

Journal
International Journal of Endocrinology
Published
2025-01-01
DOI
https://doi.org/10.1155/ije/1368301
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018

Junhe Wang, Xiaojuan Rao, Bo Huang, Jingqiu Cui et al.
International Journal of Endocrinology
Liver Disease Diagnosis and Treatment
article

Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018

Junhe Wang, Xiaojuan Rao, Bo Huang, Jingqiu Cui, Ming Rong Liu, Xinxin Zhang, Shuo Li, Tiekun Yan
article en

Abstract

<b>Background:</b> The association of vitamin D with metabolic dysfunction-associated fatty liver disease (MAFLD) remained unclear. This study aimed to examine the relationships of total 25-hydroxyvitamin D [25(OH)D, the sum of 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub>], 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD. <b>Methods:</b> We used the National Health and Nutrition Examination Survey of the 2017-2018 cycle for our present analysis. Binary logistic regression analyses were conducted to explore the associations of total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD after adjusting for confounders. Interaction tests were conducted to compare the association between 25(OH)D and MAFLD in subgroups. <b>Results:</b> The final analysis included 4605 subjects. After adjustment for confounders, the odds of MAFLD decreased with increasing concentrations of total 25(OH)D (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.29-0.68; <i>p</i> for trend < 0.001). Serum 25(OH)D<sub>3</sub> showed a strong inverse association with MAFLD (OR, 0.39; 95% CI, 0.25-0.59; <i>p</i> for trend < 0.001). In addition, participants with lower epi-25(OH)D<sub>3</sub> levels had a higher likelihood of MAFLD, as demonstrated in both quartile and continuous models (OR, 0.77; 95% CI, 0.60-0.99; <i>p</i>=0.041). After stratification by lipid status, inverse associations of total 25(OH)D and 25(OH)D<sub>3</sub> with MAFLD were found only in dyslipidemic participants (<i>p</i> for interaction < 0.001). A sex-specific interaction was also noted for 25(OH)D<sub>3</sub>, showing stronger effects in women than in men (<i>p</i>=0.036). <b>Conclusions:</b> Low serum total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> were significantly associated with a higher prevalence of MAFLD. These associations showed nonlinear patterns and were particularly evident among participants with dyslipidemia, with 25(OH)D<sub>3</sub> demonstrating stronger protective effects in women than in men. Given the cross-sectional design, causality cannot be inferred, and further prospective studies are required to confirm these findings.

International Journal of EndocrinologyVol. 2025(1)
Tianjin Medical University General Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 65%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.